首页> 外文期刊>ACS Chemical Biology >A rapid in vivo colorimetric library screen for inhibitors of microbial respiration
【24h】

A rapid in vivo colorimetric library screen for inhibitors of microbial respiration

机译:快速体内比色库筛选微生物呼吸抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

A number of fungicides that target the respiratory chain enzymes complexes II and III are used in agriculture. They are active against a large range of phytopathogens. Unfortunately, the evolution of fungicide resistance has quickly become a major issue. Resistance is often caused by mutations in the inhibitor binding domains of the complexes, and new molecules are required that are able to bypass such resistance mutations. We report here on a rapid in vivo high-throughput method, using yeast and the redox dye TTC to screen chemical libraries and identify inhibitors of respiratory function. We applied that screening process, followed by a series of tests, to a diverse library of 4,640 molecules and identified a weak inhibitor of complex III without toxic effect on the cell. Interestingly, that drug (D12) is fully active against the mutant enzyme harboring the G143A mutation that confers a high level of resistance toward most of the fungicides targeting complex III but is not active against bovine complex III. Using a collection of yeast strains harboring mutations in the inhibitor binding sites (Q _o and Q _i sites), we showed that D12 targeted the Q _o site and that its inhibitory activity was weakened by the mutation L275F. A phenylalanine is naturally present at position 275 in mammalian complex III, which could explain the differential sensitivity toward D12. The molecule is not structurally related to commercial inhibitors of complex III and could potentially be used as a lead compound for the development of antimicrobial agents.
机译:许多针对呼吸链酶复合物II和III的杀真菌剂用于农业。它们对多种植物病原体具有活性。不幸的是,抗真菌剂的发展已迅速成为一个主要问题。抗性通常是由复合物的抑制剂结合域中的突变引起的,因此需要能够绕过这种抗性突变的新分子。我们在这里报告了一种快速的体内高通量方法,使用酵母和氧化还原染料TTC筛选化学文库并鉴定呼吸功能抑制剂。我们对该筛选过程应用了筛选过程,随后进行了一系列测试,将其应用于包含4,640个分子的多样化文库,并确定了对化合物III的弱抑制剂,且对细胞无毒作用。有趣的是,该药物(D12)对具有G143A突变的突变酶具有完全活性,该突变对大多数靶向复合物III的杀真菌剂具有高水平的抗性,但对牛复合物III没有活性。使用一系列在抑制剂结合位点(Q_o和Q_i位点)具有突变的酵母菌株,我们显示D12靶向Q_o位点,并且其抑制活性因突变L275F而减弱。苯丙氨酸天然存在于哺乳动物复合物III的275位,这可以解释对D12的敏感性差异。该分子与复合物III的商业抑制剂在结构上不相关,可以潜在地用作开发抗菌剂的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号